These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 27927236)

  • 1. Chronic Infantile Neurological Cutaneous and Articular (CINCA) syndrome: a review.
    Finetti M; Omenetti A; Federici S; Caorsi R; Gattorno M
    Orphanet J Rare Dis; 2016 Dec; 11(1):167. PubMed ID: 27927236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A somatic NLRP3 mutation as a cause of a sporadic case of chronic infantile neurologic, cutaneous, articular syndrome/neonatal-onset multisystem inflammatory disease: Novel evidence of the role of low-level mosaicism as the pathophysiologic mechanism underlying mendelian inherited diseases.
    Aróstegui JI; Lopez Saldaña MD; Pascal M; Clemente D; Aymerich M; Balaguer F; Goel A; Fournier del Castillo C; Rius J; Plaza S; López Robledillo JC; Juan M; Ibañez M; Yagüe J
    Arthritis Rheum; 2010 Apr; 62(4):1158-66. PubMed ID: 20131270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of cryopyrin-associated periodic syndrome: challenges, recommendations and emerging concepts.
    Sarrabay G; Grandemange S; Touitou I
    Expert Rev Clin Immunol; 2015; 11(7):827-35. PubMed ID: 25979514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cryopyrin-associated periodic syndromes].
    Quartier P; Rodrigues F; Georgin-Lavialle S
    Rev Med Interne; 2018 Apr; 39(4):287-296. PubMed ID: 29111302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Necrotizing Funisitis as an Intrauterine manifestation of Cryopyrin-Associated Periodic Syndrome: a case report and review of the literature.
    Yokoi K; Minamiguchi S; Honda Y; Kobayashi M; Kobayashi S; Nishikomori R
    Pediatr Rheumatol Online J; 2021 May; 19(1):77. PubMed ID: 34059097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genetics of cryopyrin-associated periodic syndrome].
    Kümmerle-Deschner JB; Lohse P
    Z Rheumatol; 2017 May; 76(4):313-321. PubMed ID: 28197772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status of understanding the pathogenesis and management of patients with NOMID/CINCA.
    Goldbach-Mansky R
    Curr Rheumatol Rep; 2011 Apr; 13(2):123-31. PubMed ID: 21538043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High incidence of NLRP3 somatic mosaicism in patients with chronic infantile neurologic, cutaneous, articular syndrome: results of an International Multicenter Collaborative Study.
    Tanaka N; Izawa K; Saito MK; Sakuma M; Oshima K; Ohara O; Nishikomori R; Morimoto T; Kambe N; Goldbach-Mansky R; Aksentijevich I; de Saint Basile G; Neven B; van Gijn M; Frenkel J; Aróstegui JI; Yagüe J; Merino R; Ibañez M; Pontillo A; Takada H; Imagawa T; Kawai T; Yasumi T; Nakahata T; Heike T
    Arthritis Rheum; 2011 Nov; 63(11):3625-32. PubMed ID: 21702021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of a novel mutation in NLRP3/CIAS1 gene in an Indian child with Neonatal-Onset Multisystem Inflammatory Disease (NOMID).
    Nair SB; Chavan PP; Athalye AS; Aksentijevich I; Khubchandani RP
    Clin Rheumatol; 2019 Feb; 38(2):403-406. PubMed ID: 30066283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases.
    Aksentijevich I; Nowak M; Mallah M; Chae JJ; Watford WT; Hofmann SR; Stein L; Russo R; Goldsmith D; Dent P; Rosenberg HF; Austin F; Remmers EF; Balow JE; Rosenzweig S; Komarow H; Shoham NG; Wood G; Jones J; Mangra N; Carrero H; Adams BS; Moore TL; Schikler K; Hoffman H; Lovell DJ; Lipnick R; Barron K; O'Shea JJ; Kastner DL; Goldbach-Mansky R
    Arthritis Rheum; 2002 Dec; 46(12):3340-8. PubMed ID: 12483741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CAPS--pathogenesis, presentation and treatment of an autoinflammatory disease.
    Kuemmerle-Deschner JB
    Semin Immunopathol; 2015 Jul; 37(4):377-85. PubMed ID: 25963520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful management of cryopyrin-associated periodic syndrome with canakinumab in infancy.
    Kanariou M; Tantou S; Varela I; Raptaki M; Petropoulou C; Nikas I; Valari M
    Pediatrics; 2014 Nov; 134(5):e1468-73. PubMed ID: 25349319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal treatment of CINCA syndrome.
    Paccaud Y; Berthet G; Von Scheven-Gête A; Vaudaux B; Mivelaz Y; Hofer M; Roth-Kleiner M
    Pediatr Rheumatol Online J; 2014; 12():52. PubMed ID: 25584041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current treatment recommendations and considerations for cryopyrin-associated periodic syndrome.
    Koné-Paut I; Galeotti C
    Expert Rev Clin Immunol; 2015; 11(10):1083-92. PubMed ID: 26312542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome.
    Neven B; Marvillet I; Terrada C; Ferster A; Boddaert N; Couloignier V; Pinto G; Pagnier A; Bodemer C; Bodaghi B; Tardieu M; Prieur AM; Quartier P
    Arthritis Rheum; 2010 Jan; 62(1):258-67. PubMed ID: 20039428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational Modeling of NLRP3 Identifies Enhanced ATP Binding and Multimerization in Cryopyrin-Associated Periodic Syndromes.
    Samson JM; Ravindran Menon D; Vaddi PK; Kalani Williams N; Domenico J; Zhai Z; Backos DS; Fujita M
    Front Immunol; 2020; 11():584364. PubMed ID: 33329557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significant effect of IL-1 receptor antagonist treatment in two patients who had CINCA syndrome with constant symptoms for 13 years].
    Idorn L; Vissing NH; Jensen L; Herlin T
    Ugeskr Laeger; 2012 May; 174(22):1537-8. PubMed ID: 22668652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic NLRP3 mosaicism in Muckle-Wells syndrome. A genetic mechanism shared by different phenotypes of cryopyrin-associated periodic syndromes.
    Nakagawa K; Gonzalez-Roca E; Souto A; Kawai T; Umebayashi H; Campistol JM; Cañellas J; Takei S; Kobayashi N; Callejas-Rubio JL; Ortego-Centeno N; Ruiz-Ortiz E; Rius F; Anton J; Iglesias E; Jimenez-Treviño S; Vargas C; Fernandez-Martin J; Calvo I; Hernández-Rodríguez J; Mendez M; Dordal MT; Basagaña M; Bujan S; Yashiro M; Kubota T; Koike R; Akuta N; Shimoyama K; Iwata N; Saito MK; Ohara O; Kambe N; Yasumi T; Izawa K; Kawai T; Heike T; Yagüe J; Nishikomori R; Aróstegui JI
    Ann Rheum Dis; 2015 Mar; 74(3):603-10. PubMed ID: 24326009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subdural hemorrhage, macrocephaly, rash, and developmental delay in an infant: A pathogenic variant in NLRP3 causes CINCA/NOMID.
    Koti AS; Lanis A; Finlayson S; Canny S; Feldman EA; Miller DE; Rosenwasser N; Scott AA; Wong SC; Feldman KW
    Am J Med Genet A; 2023 Dec; 191(12):2825-2830. PubMed ID: 37548074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel knock-in mouse model of cryopyrin-associated periodic syndromes with development of amyloidosis: Therapeutic efficacy of proton pump inhibitors.
    Bertoni A; Carta S; Baldovini C; Penco F; Balza E; Borghini S; Di Duca M; Ognio E; Signori A; Nozza P; Schena F; Castellani P; Pastorino C; Perrone C; Obici L; Martini A; Ceccherini I; Gattorno M; Rubartelli A; Chiesa S
    J Allergy Clin Immunol; 2020 Jan; 145(1):368-378.e13. PubMed ID: 31194989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.